APA (7th ed.) Citation

J, S., S, K., SW, H., SW, H., SH, P., DH, Y., . . . BD, Y. (2024). Continuing or stopping 5-aminosalicylates in patients with inflammatory bowel disease on anti-TNF therapy: A nationwide population-based study. Alimentary pharmacology & therapeutics, 60(3), 389. https://doi.org/10.1111/apt.18102

Chicago Style (17th ed.) Citation

J, Seo, et al. "Continuing or Stopping 5-aminosalicylates in Patients with Inflammatory Bowel Disease on Anti-TNF Therapy: A Nationwide Population-based Study." Alimentary Pharmacology & Therapeutics 60, no. 3 (2024): 389. https://doi.org/10.1111/apt.18102.

MLA (9th ed.) Citation

J, Seo, et al. "Continuing or Stopping 5-aminosalicylates in Patients with Inflammatory Bowel Disease on Anti-TNF Therapy: A Nationwide Population-based Study." Alimentary Pharmacology & Therapeutics, vol. 60, no. 3, 2024, p. 389, https://doi.org/10.1111/apt.18102.